Treatment Registry
TR-0675 ActiveRecorded September 2026Last verified October 2026

Brand orforglipron

Sold by ZipHealth · Oral tablet · every brand orforglipron record

Price

TermPublished rateCharged today
0.8mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“0.8mg Starting at $149”

$149Published figureCharged todayNot verified
2.5mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“2.5mg Starting at $199”

$199Published figureCharged todayNot verified
5.5mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“5.5mg Starting at $299”

$299Published figureCharged todayNot verified
9mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“9mg Starting at $299”

$299Published figureCharged todayNot verified
14.5mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“14.5mg Starting at $299”

$299Published figureCharged todayNot verified
17.2mg advertised starting price; partner invoice unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Advertised

“17.2mg Starting at $299”

$299Published figureCharged todayNot verified
Price sources
Visit ZipHealth

We earn nothing from this link. It opens ZipHealth's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
States19 states: Florida, New York, Pennsylvania, Illinois, Georgia, Virginia, Colorado, Maryland, Oregon, Wisconsin, Oklahoma, Kentucky, Nebraska, Hawaii, Rhode Island, Maine, Montana, Alaska, and Wyoming
PrescriberBoth
CancellationTerms permit cancellation only before a prescription is approved; the FAQ instead describes a later pharmacy-processing cutoff. Contact support promptly and do not rely on the later window. Rejected or expired/unapproved requests receive all charged fees back; after approval the consultation portion is nonrefundable. Branded medicine order/delivery/refund issues are handled by partner pharmacies under their policies. Generic optional subscriptions require affirmative checkout consent and future cancellation, with a 48-hour shipment cutoff, while weight-loss marketing says no lock-in subscriptions. https://www.ziphealth.co/terms https://www.ziphealth.co/faq
MembershipNot disclosed
Consult fee$79. The weight-loss catalog and medicine cards separately list a clinical service and support fee per treatment. This is not established as a universal monthly membership or automatic fee on every refill. Final partner pharmacy price and any shipping are additional and must be confirmed. https://www.ziphealth.co/clinics/weight-loss/foundayo

Recorded from ziphealth.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Foundayo is orforglipron, an oral GLP-1 agonist that is neither semaglutide nor tirzepatide, so it does not fit the 'oral semaglutide' category; recorded as unspecified GLP-1 with form oral-tablet. Every order (branded and personalized/compounded alike) also carries a $79 'Clinical service and support fee' shown as an add-on on every product page in addition to the dose price.
  2. 2. October 2026 — The current weight-loss marketing says no lock-in contracts or subscriptions, while generic site terms allow optional subscriptions with affirmative checkout consent. A separate paid membership for this offer is not established. The catalog adds a $79 clinical service/support charge per treatment; this does not establish a monthly fee. https://www.ziphealth.co/clinics/weight-loss https://www.ziphealth.co/terms
  3. 3. October 2026 — The current FAQ says Wegovy, Zepbound and Foundayo are shipped by trusted partners. Manufacturer/LillyDirect contact links do not establish the actual dispensing pharmacy. The prior ZipHealth pharmacy assignment is not reconfirmed for these branded programs. Partner shipping can be separately charged; direct-ZipHealth free shipping is not universal. https://www.ziphealth.co/faq
  4. 4. October 2026 — Prices are expressly estimates, with final amounts determined by the fulfilling pharmacy. The dosage table does not establish a payment or supply interval; titration every four weeks does not create a billing period. https://www.ziphealth.co/clinics/weight-loss/foundayo

5 further notes concern other ZipHealth programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0675
Medication category
brand orforglipron
Readings
3

Related records

Cite this entry

Treatment Registry. (2026). ZipHealth — brand orforglipron (TR-0675). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0675

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.